FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011569214> ?p ?o ?g. }

• W2011569214 endingPage "555" @default.
• W2011569214 startingPage "547" @default.
• W2011569214 abstract "Ch-mAb7F9, a human-mouse chimeric monoclonal antibody (mAb) designed to bind (+)-methamphetamine (METH) with high affinity and specificity, was produced as a treatment medication for METH abuse. In these studies, we present the preclinical characterization that provided predictive evidence that ch-mAb7F9 may be safe and effective in humans. In vitro ligand binding studies showed that ch-mAb7F9 is specific for and only binds its target ligands (METH, (+)-amphetamine, and 3,4-methylenedioxy-N-methylamphetamine) with high affinity. It did not bind endogenous neurotransmitters or other medications and was not bound by protein C1q, thus it is unlikely to stimulate in vivo complement-dependent cytotoxicity. Isothermal titration calorimetry potency studies showed that METH binding by ch-mAb7F9 is efficient. Pharmacokinetic studies of METH given after ch-mAb7F9 doses in rats demonstrated the in vivo application of these in vitro METH-binding characteristics. While METH had little effect on ch-mAb7F9 disposition, ch-mAb7F9 substantially altered METH disposition, dramatically reducing the volume of distribution and clearance of METH. The elimination half-life of METH was increased by ch-mAb7F9, but it was still very fast compared with the elimination of ch-mAb7F9. Importantly, the rapid elimination of unbound METH combined with previous knowledge of mAb:target ligand binding dynamics suggested that ch-mAb7F9 binding capacity regenerates over time. This finding has substantial therapeutic implications regarding the METH doses against which ch-mAb7F9 will be effective, on the duration of ch-mAb7F9 effects, and on the safety of ch-mAb7F9 in METH users who use METH while taking ch-mAb7F9. These results helped to support initiation of a Phase 1a study of ch-mAb7F9." @default.
• W2011569214 created "2016-06-24" @default.
• W2011569214 creator A5007363821 @default.
• W2011569214 creator A5008046262 @default.
• W2011569214 creator A5021343418 @default.
• W2011569214 creator A5021626446 @default.
• W2011569214 creator A5059710385 @default.
• W2011569214 creator A5062701969 @default.
• W2011569214 creator A5066447332 @default.
• W2011569214 date "2013-12-23" @default.
• W2011569214 modified "2023-09-27" @default.
• W2011569214 title "Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use" @default.
• W2011569214 cites W1893531325 @default.
• W2011569214 cites W1964907348 @default.
• W2011569214 cites W1974747145 @default.
• W2011569214 cites W1977476611 @default.
• W2011569214 cites W2001492607 @default.
• W2011569214 cites W2007935614 @default.
• W2011569214 cites W2033503609 @default.
• W2011569214 cites W2038319340 @default.
• W2011569214 cites W2038729140 @default.
• W2011569214 cites W2041343430 @default.
• W2011569214 cites W2058038425 @default.
• W2011569214 cites W2061888707 @default.
• W2011569214 cites W2106640050 @default.
• W2011569214 cites W2118998593 @default.
• W2011569214 cites W2128783036 @default.
• W2011569214 cites W2136905779 @default.
• W2011569214 cites W2150632457 @default.
• W2011569214 cites W2152911432 @default.
• W2011569214 cites W2164431990 @default.
• W2011569214 doi "https://doi.org/10.4161/mabs.27620" @default.
• W2011569214 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3984342" @default.
• W2011569214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24492290" @default.
• W2011569214 hasPublicationYear "2013" @default.
• W2011569214 type Work @default.
• W2011569214 sameAs 2011569214 @default.
• W2011569214 citedByCount "28" @default.
• W2011569214 countsByYear W20115692142014 @default.
• W2011569214 countsByYear W20115692142015 @default.
• W2011569214 countsByYear W20115692142016 @default.
• W2011569214 countsByYear W20115692142018 @default.
• W2011569214 countsByYear W20115692142019 @default.
• W2011569214 countsByYear W20115692142020 @default.
• W2011569214 countsByYear W20115692142021 @default.
• W2011569214 countsByYear W20115692142022 @default.
• W2011569214 countsByYear W20115692142023 @default.
• W2011569214 crossrefType "journal-article" @default.
• W2011569214 hasAuthorship W2011569214A5007363821 @default.
• W2011569214 hasAuthorship W2011569214A5008046262 @default.
• W2011569214 hasAuthorship W2011569214A5021343418 @default.
• W2011569214 hasAuthorship W2011569214A5021626446 @default.
• W2011569214 hasAuthorship W2011569214A5059710385 @default.
• W2011569214 hasAuthorship W2011569214A5062701969 @default.
• W2011569214 hasAuthorship W2011569214A5066447332 @default.
• W2011569214 hasBestOaLocation W20115692141 @default.
• W2011569214 hasConcept C112705442 @default.
• W2011569214 hasConcept C150903083 @default.
• W2011569214 hasConcept C156911925 @default.
• W2011569214 hasConcept C159654299 @default.
• W2011569214 hasConcept C166940927 @default.
• W2011569214 hasConcept C178790620 @default.
• W2011569214 hasConcept C185592680 @default.
• W2011569214 hasConcept C202751555 @default.
• W2011569214 hasConcept C203014093 @default.
• W2011569214 hasConcept C207001950 @default.
• W2011569214 hasConcept C2779989194 @default.
• W2011569214 hasConcept C2780114369 @default.
• W2011569214 hasConcept C2780376393 @default.
• W2011569214 hasConcept C521977710 @default.
• W2011569214 hasConcept C542903549 @default.
• W2011569214 hasConcept C55493867 @default.
• W2011569214 hasConcept C86803240 @default.
• W2011569214 hasConcept C98274493 @default.
• W2011569214 hasConceptScore W2011569214C112705442 @default.
• W2011569214 hasConceptScore W2011569214C150903083 @default.
• W2011569214 hasConceptScore W2011569214C156911925 @default.
• W2011569214 hasConceptScore W2011569214C159654299 @default.
• W2011569214 hasConceptScore W2011569214C166940927 @default.
• W2011569214 hasConceptScore W2011569214C178790620 @default.
• W2011569214 hasConceptScore W2011569214C185592680 @default.
• W2011569214 hasConceptScore W2011569214C202751555 @default.
• W2011569214 hasConceptScore W2011569214C203014093 @default.
• W2011569214 hasConceptScore W2011569214C207001950 @default.
• W2011569214 hasConceptScore W2011569214C2779989194 @default.
• W2011569214 hasConceptScore W2011569214C2780114369 @default.
• W2011569214 hasConceptScore W2011569214C2780376393 @default.
• W2011569214 hasConceptScore W2011569214C521977710 @default.
• W2011569214 hasConceptScore W2011569214C542903549 @default.
• W2011569214 hasConceptScore W2011569214C55493867 @default.
• W2011569214 hasConceptScore W2011569214C86803240 @default.
• W2011569214 hasConceptScore W2011569214C98274493 @default.
• W2011569214 hasIssue "2" @default.
• W2011569214 hasLocation W20115692141 @default.
• W2011569214 hasLocation W20115692142 @default.
• W2011569214 hasLocation W20115692143 @default.
• W2011569214 hasOpenAccess W2011569214 @default.
• W2011569214 hasPrimaryLocation W20115692141 @default.

• next